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Abstract 
Absorption, distribution, metabolism, and excretion (ADME) studies are critical for drug 
discovery. Conventionally, these tasks, together with other chemical property predictions, rely on 
domain-specific feature descriptors, or fingerprints. Following the recent success of neural 
networks, we developed Chemi-Net, a completely data-driven, domain knowledge-free, deep 
learning method for ADME property prediction. To compare the relative performance of Chemi-
Net with Cubist, one of the popular machine learning programs used by Amgen, a large-scale 
ADME property prediction study was performed on-site at Amgen. The results showed that our 
deep neural network method improved current methods by a large margin. We foresee that the 
significantly increased accuracy of ADME prediction seen with Chemi-Net over Cubist will 
greatly accelerate drug discovery.  
 
Word count: 116/150 words.
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Introduction 
The four essential processes of drug absorption, distribution, metabolism, and excretion (ADME) 
all influence the performance and pharmacological activity of potential drugs. Over the years, the 
experimental ADME properties of many compounds have been collected by the pharmaceutical 
industry, which have been used to predict the ADME properties of new compounds. As such, 
ADME property prediction can be particularly useful in the drug discovery process to remove 
compounds which are more likely to have ADME liabilities during downstream development. 
Inspired by the huge success of deep neural networks (DNNs) in computer vision, natural 
language processing, and voice recognition, and based on their remarkable capability of learning 
concrete and sometimes implicit features 1, we hypothesized that DNNs could be used in drug 
ADME property prediction. In this paper, we extend the use of traditional statistical learning 
methods and construct a multi-layer DNN architecture, named "Chemi-Net", to predict ADME 
properties of molecule compounds.  
Applying DNNs to prediction of ADME properties has been previously reported by Ma et al. 2, 
Kearns et al. 3, and Korotcov et al.4, who all demonstrated accuracy improvements with DNNs 
over other traditional machine learning methods. However, the core challenge of ADME 
prediction using DNNs is that unlike images, which can usually be represented as a fixed-size 
data grid, molecular conformations are generally represented by a graph structure. This 
structured format is heterogeneous among molecules, which is a major problem for many 
learning algorithms that expect homogeneous input features. Several methods have been 
developed to alleviate this problem. Previous research mainly focused on transforming the graph 
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structure of molecules to a fixed size of feature descriptors. These descriptors can then be easily 
used by existing machine learning algorithms. Another method, which is popular, is the use of 
molecular fingerprints, such as those used in the Extended-Connectivity Fingerprints (ECFP) 
method 5. This method encodes the neighboring environment of heavy atoms in a compound to a 
hashed integer identifier, with each unique identifier corresponding to a unique compound 
substructure. Using this method, a compound is described as a fixed-length bit string, with each 
bit indicating whether a certain substructure is present in the compound. Such fingerprint-based 
representation makes learning graph-structured molecules possible. Neural network-based 
methods with fingerprint inputs have also been developed following recent advances in deep 
learning techniques, which have been shown to significantly improve on current Random Forest-
based models 2.However, the fingerprint-based method suffers from a fundamental issue in that 
the space required for fingerprints can be very large. Hence, the resulting fingerprints are very 
sparse. Also, the information that fingerprints encode is also noisy. Consequently, these factors 
limit the performance of fingerprint-based representations. 
Recently, there has been a growing interest in using neural networks to directly obtain a 
representation of a compound ligand before applying other layers of neural network to build the 
predictive models. These methods transform a molecule to a small and dense feature vector 
(embedding), which is friendlier to downstream learners. These methods use string-based 
representation of molecules 6, a graph convolution architecture to model circular fingerprints 7, 
and also the Weave module in which atom and pair features are combined and transformed 
through convolution-like filters 8. 
Studies to date, which have applied DNNs to ADME predications, have shown that multi-task 
deep neural networks (MT-DNNs) have advantages over traditional single-task methods 2,3.  For 
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example, MT-DNNs takes advantage of neural networks’ ability to allow use of a combinational 
model, which has predictive power for multiple activities, being simultaneously trained with data 
from different activity sets. The enhanced predictive power of MT-DNNs had not been clearly 
explained until Xu et. al,9 found that a MT-DNN borrows “signal” from molecules with similar 
structures in the training sets of the other tasks. They also found that MT-DNN outperforms the 
single- task method if the different data sets share certain connections, and the activities across 
different sets have non-random patterns.  
The potential application of MT-DNNs in pharmaceutical drug discovery is reviewed by 
Ramsundar et al.10. In this review, the authors confirmed the robustness of MT-DNNs and also 
suggested that MT-DNNs should be combined with advanced descriptors, for example, 
descriptors developed by graph convolutional methods to enhance the performance of a MT-
DNN. 
Our current application features a molecular graph convolutional network combined with the 
MT-DNN method to further boost prediction accuracy. To the best of our knowledge, there are 
no published studies that have used these combined methods. In addition, Chemi-Net implements 
a novel dynamic batching algorithm and a fine-tuning process to further improve the stability and 
performance of trained models. In this study, a large-scale ADME prediction test was carried out 
in collaboration with Amgen. The test involved five different ADME tasks with over 250,000  
data points in total. The test was conducted in a restricted environment so that the evaluation was 
only carried out once on the testing dataset. Our findings showed significant performance 
advantages with Chemi-Net over existing Cubist-based methods. 
 
7 
 
 
 
Results and Discussion 
MT-DNN method of Chemi-Net improves predictive accuracy comparing to Cubist 
Table 1 and Figure 1 shows the overall test set prediction accuracy comparison between Chemi-
Net and Cubist. Performance of models developed by different algorithms is highly dependent on 
size of data set, type of endpoint, type of model, and molecular descriptors used. For all 13 data 
sets, Chemi-Net resulted in higher R2 values compared with the Cubist benchmark. With the 
single-task method, larger and less noisy data sets yielded higher improvements than the smaller 
and noisier data sets. Additional accuracy improvement was further achieved with MT-DNN.  
 
 
CYP3A4, cytochrome P450 3A4; HLM, human microsomal clearance; PXR, pregnane X 
receptor. 
Figure 1: Absolute (left panel) and percentage (right panel) R2 improvement over Cubist using 
Chemi-Net  
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Multi-task prediction was carried out on the solubility and PXR inhibition rate data sets, as they 
had multiple subsets with large and balanced training data. Figures 2 and 3 show the absolute 
and percentage R2 increase between ST-DNN, MT-DNN and the Cubist benchmark for solubility 
and PXR inhibition, respectively. For the lower quality solubility data set, ST-DNN had lower R2 
values compared to Cubist for some subsets. In contrast, MT-DNN demonstrated dramatic 
improvements in R2 values and had higher accuracy versus Cubist for all data sets. 
 
DNN, deep neural network; HCl, hydrochloric acid; MT, multi-task; PBS, phosphate-buffered 
saline; SIF, simulated intestinal fluid; ST, single task. 
Figure 2. Absolute (left panel) and percentage (right panel) of R2 increase between ST-DNN and 
MT-DNN and the Cubist benchmark for the solubility endpoint.  
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DNN, deep neural network; MT, multi-task; PXR, pregnane X receptor. 
Figure 3. Absolute (left panel) and percentage (right panel) of R2 increase between ST-DNN, 
MTT- DNN and the Cubist benchmark for the PXR inhibition endpoint.  
 
Prediction performance and compound similarity  
We hypothesized that, as with traditional machine-learning methods, deep learning performance 
is affected by similarities between the training set and test set. To investigate this further, the 
similarity of compounds within the training set and the similarity between training and test sets 
were calculated. Similarity was calculated using molecular fingerprints and the Tanimoto method 
11. The prediction models were challenged by the test sets, which contained newer compounds 
and novel chemotypes. For all 13 data sets, the average similarity within training sets was 0.878, 
and the average similarity between training and test sets was only 0.679. 
Figure 4 shows the prediction performance in comparison to the similarity between training and 
test sets. In the same type of assay (e.g. solubility or PXR), prediction performance correlated 
with the overall compound similarity between training and test sets for both Cubist and Chemi-
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Net. To further illustrate the similarity influence of prediction accuracy, one data set was chosen, 
solubility (HCl), and the compounds in the test set were binned based on their similarity to the 
training set. The binned compounds were then correlated with their prediction accuracy (Figure 
5). Unsurprisingly, the R2 increased as the similarity between training and the test set increased 
with both the Chemi-Net and Cubist models. This results strongly suggests our hypothesis is 
correct. 
 
HLM, human microsomal clearance (HLM); HCl, hydrochloric acid; PBS, phosphate-buffered 
saline; pregnane X receptor; SIF, simulated intestinal fluid; ST, single-task; MT, multi-task. 
Figure 4. Prediction performance and similarity between training and test sets for all 13 data 
sets.  
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HCl, hydrochloric acid. 
Figure 5. Prediction performance of binned test set compounds by similarity for the solubility 
(HCl) data set: Chemi-Net ST-DNN (left-hand panel) and Cubist (right-hand panel). 
 
Comparison between Chemi-Net’s descriptors and Amgen’s traditional property and 
molecular keys descriptors 
Chemi-Net applies molecular graph convolutional networks to generate descriptors on a three-
dimensional (3D) level based on simplified molecular-input line-entry system (SMILES) strings. 
Over the past 10 years, Amgen has used a set of 800 more “traditional” 1-dimensional (1D) and 
two-dimensional (2D) descriptors based on physical properties, molecular keys etc. In our 
current study, we compared the two sets of descriptors by using the same ST-DNN methods in 
Chemi-Net (Figure 6). Interestingly, the Amgen “traditional” descriptor set, and the Chemi-Net 
descriptor sets performed similarly in some data sets (i.e. Solubility [HCL and SIF], PXR 
[Subset 2, 5 and 6]). For large and relatively high-quality data sets (e.g. HLM, CYP3A4) Chemi-
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Net descriptor sets performed better than Amgen descriptor set. In contrast, for small and noisy 
data sets (e.g. PXR and bioavailability) the Amgen descriptor set performed better. 
 
 
CYP3A4, cytochrome P450 3A4; human microsomal clearance (HLM); HCl, hydrochloric acid; 
PBS, phosphate-buffered saline; PXR, pregnane X receptor. 
Figure 6. Comparison between Chem-Net molecular graph convolutional network derived 
descriptors and traditional descriptors. 
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Conclusion  
In this proof-of-concept study, we report for the first time the use of applying a molecular graph 
convolutional network combined with the MT-DNN method (Chemi-Net) to predict drug 
properties in a series of industrial grade datasets. The major improvements of this method are 
two-fold. First, instead of relying on preset descriptors (features) as reported in previously 
reported studies 2, it used a graph convolution method to extract features from the smile file of 
each compound. Second, the multi-task DNN method used further improved on the individual 
model, which is limited by the fewer data points in an individual dataset. Given the clear 
performance improvement across all assay types, we foresee the wider application of our 
approach in drug discovery tasks. 
 
Methods 
Deep neural network-based model 
Conventional fingerprint and pharmacophore methods usually require that explicit features are 
extracted and trained, hence the forms of the fingerprints are often limited by human prior 
knowledge. Encouraged by recently-reported studies in which DNNs have been shown to surpass 
human capability in multiple types of tasks from pattern recognition to playing the game Go 12, 
we decided to use a DNN architecture to develop an ADME property prediction system. The 
overall neural network architecture is shown in Figure 7. This network accepts a molecule input 
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with given 3D coordinates of each atom. It then processes the input with several neural network 
operations and then outputs the ADME properties predicted for the input molecule. 
 
 
Figure 7. Overall network architecture. The input is quantized as molecule-shaped graph 
structure. Then a series of graph-based convolution operators are applied. In this figure, red 
highlights the central atom, and pink highlights concerned neighbor atoms. In the second 
convolution layer, purple also highlights the information flow area from the previous 
convolution step. 
 
In the model presented in this paper, the input molecule is represented by a set of distributed 
representations assigned to its atoms and atom pairs. Each atom and atom pair are assigned a 
dense feature map, with 𝐴𝑎 defined as the feature map of atom 𝑎, and 𝑃𝑎,𝑏 defined as the feature 
map of atom pair 𝑎 and 𝑏. Typical atom features include atom type, atom radius, and whether the 
atom is in an aromatic ring. Typical atom pair features include the inter-atomic distance and the 
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bond orders between two atoms. The input molecule is then represented by a set of atom features 
{𝐴1, 𝐴2, . . . , 𝐴𝑛} and atom pair features {𝑃1,2, 𝑃1,3, . . . , 𝑃𝑛−1,𝑛}. 
 
After the input atom level and atom pair level features are assembled, they are combined to form 
a molecule-shaped graph structure. A series of convolution operators are then applied to the 
graph, each operator then performs a convolution operation, which transforms the atom feature 
maps. To enable position invariant handling of atom neighbor information, the convolution 
filters for all atoms share a single set of weights. The output of the convolution layers is a set of 
representations for each atom. The pooling step reduces the potentially variable number of atom 
feature vectors into a single fixed-sized molecule embedding. The molecule embedding is then 
fed through several fully connected layers to obtain a final predicted ADME property value. 
  
Convolution operator 
The convolution operator is inspired by the Inception 13 and Weave modules 8. The overall 
convolution operator structure is depicted in Figure 8. The inputs of this operator are the feature 
maps of the atoms and atom pairs. In this operator, the feature map of each atom is updated by 
first transforming the features of its neighbor atoms and atom pairs, then reducing the potentially 
variable-sized feature maps to a single feature map by using a commutative reducing operator. 
Importantly, atom pair features are never changed throughout the process. 
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Figure 8. Convolution filter structure. 
 
The method used to update the feature map of each atom is the same for all atoms. They are 
formulated with shared weights to achieve position-invariant behavior. Hence this process can be 
viewed as the same convolutional operation seen in convolutional neural networks (CNNs), 
except that the convolution filter connections are dynamic instead of fixed. This operator is 
designed so that an arbitrary number of these operators can be stacked. As in DNNs, the 
increased number of stacking operators enables more complex structures of the molecule to be 
learned. A typical computation flow of a convolution filter is shown in Figure 8. The most 
important aspects of the filter are the transformation and reduction operators. 
 
In the transformation step, feature maps of neighbors of an atom are transformed by a feed-
forward sub-network. For a neighbor atom 𝑏 of central atom 𝑎, the input feature map is the 
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concatenation of atom feature 𝐴𝑏 and the atom pair feature 𝑃𝑎,𝑏. The bias term is denoted as 𝐵. 
The input is transformed through one fully connected layer and a non-linearity function 𝑓: 
𝑇𝑎,𝑏
𝑘 = 𝑓(𝑊𝑘(𝐶𝑜𝑛𝑐𝑎𝑡{𝐴𝑏
𝑘 , 𝑃𝑎,𝑏}) + 𝐵
𝑘) 
After each neighbor atom of 𝑎 is transformed, these feature maps are then aggregated and 
reduced to a single feature map. In this process, a commutative reduction function is used to keep 
the order-invariant nature of the input feature maps. A typical example of such a function is the 
element-wise sum function 𝑆𝑢𝑚{⋅}, which for input vectors 𝑋1, 𝑋2, . . . , 𝑋𝑛, the output vector 𝑌 is 
defined as 𝑌𝑗 = ∑ 𝑋𝑖𝑗
𝑛
𝑖 . Similarly, we define operator 𝑀𝑎𝑥{⋅} for element-wise max and 𝐴𝑣𝑔{⋅} 
for element-wise averaging. 
Following these principles, a reduction operator is constructed to improve model quality, in 
which multiple kinds of reduction operations are performed simultaneously and their outputs are 
combined as shown in Figure 9: 
𝑅𝑎
𝑘 = 𝐶𝑜𝑛𝑐𝑎𝑡{𝑀𝑎𝑥{𝑋𝑎
𝑘}, 𝑆𝑢𝑚{𝑋𝑎
𝑘}, 𝐴𝑣𝑔{𝑋𝑎
𝑘}} 
where 
𝑋𝑎
𝑘 = {𝑇𝑎,𝑏
𝑘 |𝑏 ∈ 𝑛𝑒𝑖𝑔ℎ𝑏𝑜𝑟{𝑎}} 
 
The reduced feature map is then combined with the input feature map of atom 𝑎 (Figure 8) to 
produce the final output. This enables the model to obtain feature maps from different 
convolution levels, which are more straightforward and easier to optimize than only using the 
reduced feature map 14: 
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𝐴𝑎
𝑘+1 = 𝐶𝑜𝑛𝑐𝑎𝑡{𝐴𝑎
𝑘 , 𝑅𝑎
𝑘} 
In our experiments, the non-linearity 𝑓 is the Leaky ReLU function with negative slope 𝛼 =
0.01: 
𝑓(𝑥) = {
𝑥, 𝑖𝑓 𝑥 > 0
 𝛼𝑥, 𝑜𝑡ℎ𝑒𝑟𝑤𝑖𝑠𝑒
 
For each convolutional layer, a batch normalization operation 15 is applied on all atom 
embeddings of the entire batch, to accelerate the training process. 
 
 
Max, maximum; Avg, average. 
 
Figure 9. The reduction step in convolution filter.  
 
Input quantization 
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The initial input of the atom level features 𝐴𝑖 and pair level features 𝑃𝑖𝑗 contains the entries listed 
in Table 2 and Table 3. 
 
Multi-task learning 
In ADME profiling in drug discovery, data sets of the same domain problem but different 
conditions, such as experimental settings, are usually found. For example, the aqueous 
equilibrium solubility of ligands in certain media (e.g. HCl), is correlated with those under 
different media (e.g. PBS), albeit they are not completely equivalent. A model targeting multiple 
related tasks will be much more powerful than independent models for each task. 
As shown in Figure 10, our MT-DNN model extends the single-task model in a joint learning 
setup. The embedding for each ligand is trained and then used to predict multiple-task scores 
simultaneously. When training, the loss functions of each task are summed to get the final loss 
function. Furthermore, the weight of individual tasks can be non-uniform. This is useful for 
scenarios which favor one task over other tasks. 
 
 
Figure 10. Joint training model for multi-task learning. 
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Fine-tuning 
Due to the noisy nature of stochastic optimization algorithms, the validation and testing accuracy 
of neural network models varies greatly for each epoch. Hence, to obtain a stable model with 
consistent predictive power, some form of post-processing and model selection will be needed. 
In this paper, we provide a fine-tuning process, which combing model selection and ensemble to 
further improve the stability and performance of single-shot models. 
The fine-tuning process works as shown in Figure 11. First, input data is trained by multiple 
network configurations consisting of different layer structures; then, several of the best 
performing models out of trained epochs of these models are selected, based on their validation 
accuracy. Finally, the embeddings and prediction results of these models are used by the fine-
tuning algorithm to train a fine-tuning model, which ensembles these embeddings and produces a 
model with improved accuracy. 
The outputted embeddings and prediction scores for each selected model give the input of the 
fine-tuning model. The ensemble model consists of several multi-layer perceptrons. Order-
independent reduction layers are also used to compress information from arbitrary number of 
models to a fixed size. After these embeddings and scores are transformed by the neural network, 
a final ligand embedding is produced. This embedding may be combined with an optional 
explicit feature vector to include any existing engineered ligand descriptors. The combined 
embedding is then transformed by a multi-layer perceptron to obtain the final predicted score. 
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Figure 11. Fine-tuning algorithm. 
 
Benchmark method: Cubist 
Cubist is a very useful tool in analyzing large and diverse set of data, especially data with non-
linear structure-activity relationships (SARs) 16,17. It is a statistical tool for generating rule-based 
predictive models and resembles a piecewise linear regression model 18, except that the rules can 
overlap. Cubist does this by building a model containing one or more rules, where each rule is a 
conjunction of conditions associated with a linear regression. The predictive accuracy of a rule-
based model can be improved by combining it with an instance-based or nearest-neighbor based 
model. The latter predicts the target value of a new case by finding a predefined number of most 
similar cases in the training data and averaging their target values. Cubist then combines the rule-
based prediction with instance-based prediction to give a final predicted value. Cubist release 
2.04 was used in this study. 
 
Benchmark Descriptors  
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Two-dimensional molecular descriptors were used for in silico ADME modeling. These include 
cLogP (BioByte Corp., Claremont, CA), Kier connectivity, shape, and E-state indices 19–21 a 
subset of MOE descriptors (Chemical Computing Group Inc., 2004, MOE 2004.03, 
http://www.chemcomp. com), and a set of ADME keys that are structural features used for 
ADME modeling 22. Some of the descriptors such as Kier shape indices contain implicit 3D 
information. Explicit 3D molecular descriptors were not routinely used in this study to avoid bias 
of the analysis due to predicted conformational effects and speed of calculation for fast 
prediction. 
 
Data sets  
A large-scale test was performed on Amgen’s internal data sets using five ADME endpoints and 
a total of 13 data sets selected for building predictive model. The five selected ADME endpoints 
were human microsomal clearance (HLM), human CYP450 inhibition (CYP3A4), aqueous 
equilibrium solubility, pregnane X receptor (PXR) induction, and bioavailability. For the 
CYP3A4 assay, two subsets were studied, which differed slightly with conditions. For the 
aqueous equilibrium solubility assay, three subsets were studied: hydrochloric acid (HCl), 
phosphate-buffered saline (PBS), and simulated intestinal fluid (SIF). For the PXR induction 
assay, six subsets were studied, which differed slightly with conditions. Across all ADME 
endpoints, the data sets used varied in quality and quantity. Generally speaking, PXR and 
bioavailability data sets were noisier than the data sets for the three other ADME endpoints. 
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The training set and test set were split in an approximate ratio of 80:20 (Table 4). To resemble 
real-time prediction situations, compounds were ranked with their registration data in 
chronological order. Newer compounds were selected in the test set.  
 
Model training and test procedure: 
The test set was used solely for testing purposes to avoid bias in the training procedure. The 
Caret package in R was used for the Cubist method. A 10-fold cross validation was applied to 
tune parameters (committee member and number of nearest neighbors). A Caret-implemented 
grid search was then used to select the best parameter set to produce final models, using the 
lowest root mean-squared error (RMSE) for testing. For Chemi-Net, the input SMILES were first 
converted to 3D structures using an internal molecular conformation generator. The resultant 
molecular graphs were then used for training and testing. An RMSE-based loss function was 
used for training the neural network. A standard neural network procedure using the Adam 
optimizer 23 was applied. Both the single-task and multi-task models were evaluated. The fine-
tuning process was performed on all tests. 
The Cubist benchmark calculation was performed in parallel on an internal CPU cluster. The 
Chemi-Net calculation was carried out on six Amazon Web Service (AWS) EC2 p2.8xlarge 
GPU instances. 
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Figure legends 
Figure 1: Absolute (left panel) and percentage (right panel) R2 improvement using Chemi-Net 
from Cubist.  
Figure 2. Absolute (left panel) and percentage (right panel) of R2 increase between ST-DNN and 
MT-DNN and the Cubist benchmark for the solubility endpoint.  
Figure 3. Absolute (left panel) and percentage (right panel) of R2 increase between ST-DNN, 
MTT- DNN and the Cubist benchmark for the PXR inhibition endpoint.  
Figure 4. Prediction performance and similarity between training and test sets for all 13 data 
sets. 
Figure 5. Prediction performance of binned test set compounds by similarity for the solubility 
(HCl) data set: Chemi-Net ST-DNN (left-hand panel) and: Cubist (right-hand panel). 
Figure 6. Comparison between Chem-Net molecular graph convolutional network derived 
descriptors and traditional descriptors. 
Figure 7. Overall network architecture. The input is quantized as molecule-shaped graph 
structure. Then a series of graph-based convolution operators are applied. In this figure, red 
highlights the central atom, and pink highlights concerned neighbor atoms. In the second 
convolution layer, purple also highlights the information flow area from the previous 
convolution step. 
Figure 8. Convolution filter structure. 
Figure 9. The reduction step in convolution filter.  
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Figure 10. Joint training model for multi-task learning. 
Figure 11. Fine-tuning algorithm. 
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Table 1. Test set results 
Dataset Subset Train 
Size 
Test 
Size 
Cubist Chemi-Net 
ST-DNN 
Chemi-Net 
MT-DNN 
HLM 1 69,176 17,294 0.39 0.445  
CYP450  1 3,019 755 0.597 0.692  
2 71,695 17,924 0.315 0.414  
Solubility 1 (HCl) 10,650 2,659 0.493 0.548 0.585 
2 
(PBS) 
10,650 2,664 0.393 0.471 0.498 
3 (SIF) 10,650 2,645 0.445 0.552 0.562 
PXR 1 @ 2 
uM 
19,902 4,981 0.276 0.257 0.422 
2 @ 10 
uM 
17,414 4,256 0.343 0.333 0.445 
3 @ 2 
uM 
8,883 2,223 0.094 0.11 0.199 
4 @ 10 
uM 
8,205 2,054 0.246 0.2 0.327 
5 @ 10 
uM 
10,047 2,511 0.349 0.38 0.418 
6 @ 2 
uM 
10,047 2,536 0.283 0.311 0.352 
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Bioavailability 1 183 46 0.115 0.123  
CYP450, cytochrome P450; DNN, deep neural network; HCl, hydrochloric acid HLM, human 
microsomal clearance; MT-DNN, multi-task deep neural network; PBS, phosphate-buffered 
saline; PXR, pregnane X receptor; SIF, simulated intestinal fluid; ST-DNN, single-task DNN. 
 
Table 2. Atom Features. 
Atom feature Description Size 
Atom type One hot vector specifying the type of this atom. 23 
Radius vdW radius and covalent radius of the atom. 2 
In rings For each size of ring (3-8), the number of rings that 
include this atom. 
6 
In aromatic ring Whether this atom is part of an aromatic ring. 1 
Charge Electrostatic charge of this atom. 1 
 
Table 3. Pair features. 
Pair feature Description Size 
Bond type One hot vector of {Single, Double, None}. 3 
Distance Euclidean distance between this atom pair. 1 
Same ring Whether the atoms are in the same ring. 1 
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Table 4. Dataset details 
Dataset Subset Train Size Test Size 
Human microsomal intrinsic clearance log10 
rate) (µL/min/mg protein) 
1 69,176 17,294 
Human CYP450 inhibition log10(IC50 µM) 1 3,019 755 
2 71,695 17,924 
Solubility log10 (µM) 1 (HCl) 10,650 2,659 
2 (PBS) 106,50 2,664 
3 (SIF) 10,650 2,645 
PXR induction (POC) 1 @ 2 uM 19,902 4,981 
2 @ 10 uM 17,414 4,256 
3 @ 2 uM 8,883 2,223 
4 @ 10 uM 8,205 2,054 
5 @ 10 uM 10,047 2,511  
6 @ 2 uM 10,047 2,536 
Bioavailability 1 183 46 
CYP450, cytochrome P450; HCl, hydrochloric acid; IC50: half maximal inhibitory concentration; 
phosphate-buffered saline; pregnane X receptor; POC, percentage of control; SIF, simulated 
intestinal fluid. 
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Supplementary information 
Dynamic batching algorithm 
Most neural network models use stochastic gradient descent or one of its variants for 
optimization. Mini-batched inputs are generally favored instead of feeding individual instances 
one by one in order to reduce instance variance in stochastic optimization and computation 
overhead during training process. In most CNN models, the computation graph can be statically 
determined and is the same for all input data. In these cases, mini-batching can be easily 
implemented, as is done in most DNN frameworks. However, the structure of the graph defined 
by the CNN in this current study depends on the input molecules, thus it has highly dynamic and 
different computation graphs. Conventional neural network implementations fail to support 
batching on such a model because the computation graph is heterogeneous for each input. To 
overcome this issue with Chemi-Net, an efficient dynamic batching algorithm was designed. 
This algorithm analyzes the computation graph for each input batch dynamically and merges 
CNN operations without affecting the computation correctness. Additionally, unlike CNN 
implementations, which only supports batching at training instance level, our approach supports 
batching neural network operations in intra and inter instances. This is essential for a correct 
batch normalization implementation, and important for efficiently running heterogeneous 
convolution layers. 
 
The detailed dynamic batching algorithm is shown in Figure S1. The algorithm can be divided 
into three steps: computation graph initialization, batching analysis, and gather/scatter operation 
generation. During initialization, the original un-batched computation graph for each input 
instance is generated. The computation graph is a directed acyclic graph (DAG). In the batching 
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analysis step, the structure of the computation graph is examined so that compatible operations 
without data dependency are batched. In the gather/scatter operation generation step, gather and 
scatter operations are generated for the inputs and outputs of a batched operation. An 
optimization is also performed in this step so that a scatter-gather operation pair between two 
batched operations can be eliminated. 
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Figure S1. Dynamic batching algorithm. 
 
